Capecitabine and Bevacizumab ± Vinorelbine in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Vinorelbine
Related studies linked through entity extraction aliases.
Cilengitide and Cetuximab in Combination With Platinum-based Chemotherapy as First-line Treatment for Subjects With Advanced Non Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy , Safety of Treatment R NIMP for Relapsed Aggressive Lymphomas
- Status
- COMPLETED
- Phase
- PHASE2
A Feasibility Trial of Avastin (Bevacizumab) in Combination With Concomitant Chemoradiation (Cisplatin and Vinorelbine) in Patients With Locally Advanced Non-Squamous Non-Small Cell Lung Cancer.
- Status
- COMPLETED
- Phase
- PHASE1
Metronomic Vinorelbine and Bevacizumab in Patients With Non Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Vinorelbine Metronomic Plus Lapatinib for Overexpressing HER-2 Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Vinorelbine/Gemcitabine Versus Vinorelbine/Carboplatin in Advanced Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Concomitant Chemoradiotherapy With Weekly Paclitaxel and Vinorelbine and Granulocyte Colony Stimulating Factor (GCSF) Support in Patients With Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study Evaluating Neratinib (HKI-272) In Combination With Vinorelbine In Subjects With Solid Tumors And Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Individualized Therapy Based of Tumoral mRNA Levels of ERCC1, RRM1 and BRCA1 in Advanced Non-Small-Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Vinorelbine Metronomic Plus Bevacizumab as Salvage Therapy for Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Bevacizumab in Combination With Vinorelbine and Trastuzumab for HER2-Positive, Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel/Bevacizumab Combination in Locally Advanced or Metastatic NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
An Efficacy and Safety Study With Vandetanib to Treat Inoperable or Relapsed Malignant Mesothelioma
- Status
- TERMINATED
- Phase
- PHASE2
Lapatinib and Vinorelbine in Treating Women With HER2-Overexpressing Locally Advanced or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Neoadjuvant Trial of Trastuzumab in Combination With Dose-Dense ABI-007 (Abraxane™)
- Status
- COMPLETED
- Phase
- PHASE2
Phase III of RRM1 & ERCC1 Directed Customized Chemotherapy for the Treatment of Patients With NSCLC
- Status
- COMPLETED
- Phase
- PHASE3
Gemcitabine/Vinorelbine Versus Gemcitabine/Cisplatin Versus Gemcitabine/Capecitabine in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Post-transplant Autologous Cytokine-induced Killer (CIK) Cells for Treatment of High Risk Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1